Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial.

[1]  C. Granger,et al.  Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology , 2020, European heart journal. Acute cardiovascular care.

[2]  J. Messenger,et al.  Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock. , 2020, JAMA.

[3]  J. Spertus,et al.  The Evolving Landscape of Impella Use in the United States Among Patients Undergoing Percutaneous Coronary Intervention With Mechanical Circulatory Support , 2019, Circulation.

[4]  E. Ohman,et al.  Management of cardiogenic shock complicating myocardial infarction: an update 2019. , 2019, European heart journal.

[5]  A. Boulesteix,et al.  Extracorporeal Life Support in Cardiogenic Shock Complicating Acute Myocardial Infarction. , 2019, Journal of the American College of Cardiology.

[6]  C. Terkelsen,et al.  Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. , 2019, American heart journal.

[7]  S. Blankenberg,et al.  Impella Support for Acute Myocardial Infarction Complicated by Cardiogenic Shock: Matched-Pair IABP-SHOCK II Trial 30-Day Mortality Analysis , 2019, Circulation.

[8]  A. Kirtane,et al.  Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock. , 2019, Journal of the American College of Cardiology.

[9]  Volkmar Falk,et al.  2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.

[10]  H. Thiele,et al.  Intraaortic Balloon Pump in Cardiogenic Shock Complicating Acute Myocardial Infarction: Long-Term 6-Year Outcome of the Randomized IABP-SHOCK II Trial , 2019, Circulation.

[11]  S. Blankenberg,et al.  Unloading of the Left Ventricle During Venoarterial Extracorporeal Membrane Oxygenation Therapy in Cardiogenic Shock. , 2018, JACC. Heart failure.

[12]  D. Brodie,et al.  Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome , 2018, The New England journal of medicine.

[13]  Marco Valgimigli,et al.  2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). , 2018, European heart journal.

[14]  J. Wald,et al.  Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States , 2018, Clinical Research in Cardiology.

[15]  H. Thiele,et al.  Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials , 2017, European heart journal.

[16]  H. Thiele,et al.  PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock , 2017, The New England journal of medicine.

[17]  E. Ohman,et al.  Contemporary Management of Cardiogenic Shock: A Scientific Statement From the American Heart Association , 2017, Circulation.

[18]  M. Hromadka,et al.  Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO‐CS): rationale and design of the multicenter randomized trial , 2017, European journal of heart failure.

[19]  J. Maessen,et al.  Modalities and Effects of Left Ventricle Unloading on Extracorporeal Life support: a Review of the Current Literature , 2017, European journal of heart failure.

[20]  H. Thiele,et al.  Risk Stratification for Patients in Cardiogenic Shock After Acute Myocardial Infarction. , 2017, Journal of the American College of Cardiology.

[21]  G. Schuler,et al.  Outcome of elderly undergoing extracorporeal life support in refractory cardiogenic shock , 2017, Clinical Research in Cardiology.

[22]  B. D. de Mol,et al.  Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis , 2016, Intensive Care Medicine.

[23]  G. Schuler,et al.  Long-term prognosis after extracorporeal life support in refractory cardiogenic shock: results from a real-world cohort. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[24]  J. Messenger,et al.  Use of Mechanical Circulatory Support in Patients Undergoing Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry , 2015, Circulation.

[25]  G. Schuler,et al.  Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial , 2013, The Lancet.

[26]  G. Schuler,et al.  Intraaortic balloon support for myocardial infarction with cardiogenic shock. , 2012, The New England journal of medicine.

[27]  A. Pavie,et al.  Predictors of successful extracorporeal membrane oxygenation (ECMO) weaning after assistance for refractory cardiogenic shock , 2011, Intensive Care Medicine.

[28]  Marco Valgimigli,et al.  Standardized Bleeding Definitions for Cardiovascular Clinical Trials: A Consensus Report From the Bleeding Academic Research Consortium , 2011, Circulation.

[29]  L. Sleeper,et al.  SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK: an international randomized trial of emergency PTCA/CABG-trial design. The SHOCK Trial Study Group. , 1999, American heart journal.

[30]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .